Furthermore, de Luna et al. propose that assessing leukocyte myophosphorylase expression may serve as a useful, non-invasive diagnostic tool for McArdle disease [11], particularly when novel or clinically indeterminate genetic variants are identified. This evidence concerns the gene PYGM and glycogen storage disease V.